As we noted in yesterday's research note, in Tuesday night's press release, USNA initiated 2026 EPS guidance of $1.95-$2.29, versus our previous estimate of $1.84.
Under the leadership of Kevin Guest (who returned to the CEO position in early January), USNA is looking to accelerate technology modernization, including greater use of third-party platforms and AI.
That said, these technology investments are not yet embedded in the earnings guidance but will be provided by USNA at a later date.
Hence, at this point, we raise our 2026 EPS estimate to $2.00 (from $1.84) and maintain our 2027 EPS forecast of $2.77.
Otherwise, we still expect the company to maintain a strong balance sheet and generate free cash flow of about $1-$2 per share annually through 2027.
We maintain our $39 price target, which is based on 14x our 2027 EPS estimate of $2.77.
Our moderate risk rating on USNA factors in the company's solid, cash rich balance sheet and good free cash flow prospects.
19 Feb 2026
Raise 2026 EPS Estimate After The Conference Call As New CEO Looks To Position USNA To Be A Modern, Science-Driven Nutrition Products Company; Maintain $39 Price Target
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Raise 2026 EPS Estimate After The Conference Call As New CEO Looks To Position USNA To Be A Modern, Science-Driven Nutrition Products Company; Maintain $39 Price Target
USANA Health Sciences (USNA:NYSE) | 0 0 0.0%
- Published:
19 Feb 2026 -
Author:
Anthony C. Lebiedzinski -
Pages:
10 -
As we noted in yesterday's research note, in Tuesday night's press release, USNA initiated 2026 EPS guidance of $1.95-$2.29, versus our previous estimate of $1.84.
Under the leadership of Kevin Guest (who returned to the CEO position in early January), USNA is looking to accelerate technology modernization, including greater use of third-party platforms and AI.
That said, these technology investments are not yet embedded in the earnings guidance but will be provided by USNA at a later date.
Hence, at this point, we raise our 2026 EPS estimate to $2.00 (from $1.84) and maintain our 2027 EPS forecast of $2.77.
Otherwise, we still expect the company to maintain a strong balance sheet and generate free cash flow of about $1-$2 per share annually through 2027.
We maintain our $39 price target, which is based on 14x our 2027 EPS estimate of $2.77.
Our moderate risk rating on USNA factors in the company's solid, cash rich balance sheet and good free cash flow prospects.